Expert Committee: FDA Should Allow Mitochondrial Replacement Trials Under Certain Conditions
Links
From the article:
Glenn Cohen, faculty director of the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School, wrote on the center’s blog Wednesday: “The big headline is they have recommended FDA largely move toward allowing [MRT] to go forward under a regulatory pathway with restrictions, the most important of which is the transfer only of male embryos (to avoid germ-line issues)."
fda health law policy i. glenn cohen regulation reproductive rights